Mesenchymal stem cell transplantation alleviated TBI-induced lung injury by inhibiting PAD4-dependent NET formation

Our findings demonstrate that hUC-MSCs significantly alleviate TBI-induced lung injury by inhibiting neutrophil infiltration and NET formation, offering potential therapeutic benefits for treating TBI-associated lung complications. These results highlight the clinical potential of hUC-MSCs in addressing both neurological and pulmonary damage in TBI patients.